RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FACCHINETTI F
Collezione AO Ordine Mauriziano

Items : 8

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.

2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Planchard D; Besse B; Novello S; Barlesi F; Le Péchoux C; Facchinetti F; Aldea M; Genova C; Bironzo P; Di Maio M; Remon J; Tagliamento M; Tagliamento M; Di Maio M; Remon J; Bironzo P; Genova C; Facchinetti F; Aldea M; Le Péchoux C; Novello S; Barlesi F; Besse B; Planchard D;

Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Feb;180:117-124. doi: 10.1016/j.ejca.2022.12.005. Epub 2022 Dec 12.

2023
AO Ordine Mauriziano

Remon J; Villacampa G; Facchinetti F; Di Maio M; Marcuse F; Tiseo M; Hochstenbag M; Hendriks LEL; Besse B; Remon J; Villacampa G; Facchinetti F; Di Maio M; Marcuse F; Tiseo M; Hochstenbag M; Hendriks LEL; Besse B;

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. in Journal for immunotherapy of cancer / J Immunother Cancer. 2022 Feb;10(2):e004374. doi: 10.1136/jitc-2021-004374.

2022
AO Ordine Mauriziano

Cortellini A; Ricciuti B; Vaz VR; Soldato D; Alessi JV; Dall'Olio FG; Banna GL; Muthuramalingam S; Chan S; Majem M; Piedra A; Lamberti G; Andrini E; Addeo A; Friedlaender A; Facchinetti F; Gorría T; Mezquita L; Hoton D; Valerie L; Nana FA; Artingstall J; Comins C; Di Maio M; Caglio A; Cave J; McKenzie H; Newsom-Davis T; Evans JS; et alii...

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2890-2916. doi: 10.21037/tlcr-20-941.

2021
AO Ordine Mauriziano

Facchinetti F; Di Maio M; Friboulet L; Tiseo M; Guaitoli G;

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2917-2936. doi: 10.21037/tlcr-21-15.

2021
AO Ordine Mauriziano

Perrone F; Di Maio M; Facchinetti F; Tiseo M;

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials. in Cancers / Cancers (Basel). 2020 Sep 16;12(9):2645. doi: 10.3390/cancers12092645.

2020
AO Ordine Mauriziano

Facchinetti F; Di Maio M; Tiseo M;

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baldessari C; Novello S; Bartoli G; Pizzutilo EG; Landi L; Dall'Olio FG; Toschi L; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Bearz A; Camerini A; Sala E; Migliorino MR; Cerea G; Ardizzoni A; Bennati C; Vita E; Del Conte A; Rossi S; Scotti V; Pilotto S; Cecere FL; Proto C; Berardi R; Mazzoni F; et alii...

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Jun;5(3):301-21. doi: 10.21037/tlcr.2016.06.10.

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Rossi G; Bria E; Graziano P; Di Maio M; Tiseo M; Facchinetti F;